Novus Pharmaceuticals Limited
About Novus Pharmaceuticals Limited
Data last updated:
Novus Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 June 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1995PLC089743. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.32 Cr. It is led by directors including Pramod Sitaram Saraf and Omprakash Sitaram Saraf.
Its last annual general meeting (AGM) was held on 30 September 2010, and its latest financial statements are for the year ended 31 March 2010. The registered office is at 17/23 Shreenath Ind Estatemahakali Rd Andheri (E), Mumbai, Maharashtra, India – 400093.
As per MCA filings, the company has open charges of ₹3.1 Cr on record. Court records list 5 cases involving the company, including 5 filed against it.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
CIN history
Novus Pharmaceuticals has one previous CIN (Corporate Identification Number): L24230MH1995PLC089743. The current CIN is U24230MH1995PLC089743, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH1995PLC089743 | Current |
| L24230MH1995PLC089743 | Previous |
Contact details
Novus Pharmaceuticals Limited's registered office is in Mumbai, Maharashtra.
- Registered Address17/23 Shreenath Ind Estatemahakali Rd Andheri (E), Mumbai, Maharashtra, India – 400093
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Novus Pharmaceuticals Limited
FY 2010 filings availableFinancial Statement Summary
| Metrics | FY 2009-10 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2009-10 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Novus Pharmaceuticals Limited, buy the company report.
Board of directors of Novus Pharmaceuticals Limited
Novus Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pramod Sitaram Saraf | Director | 20 Jun 1995 | 31 Years 4 Months | Current |
| Omprakash Sitaram Saraf Also directs: Novus Remedies Private Limited | Director | 26 Jun 1995 | 31 Years 4 Months | Current |
| Subhashchandra Khetaram Choudhary | Director | 20 Jun 1995 | 31 Years 4 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Feb 2001 | 90157663 | Development Credit Bank Ltd. | ₹10 Lakh | Open | |
| 15 Mar 2000 | 90157442 | Development Credit Bank Ltd. | ₹20 Lakh | Open | |
| 15 Mar 2000 | 90159908 | Development Credit Bank Ltd. | ₹15 Lakh | Open | |
| 13 Mar 2000 | 90159906 | Development Credit Bank Ltd. | ₹10 Lakh | Open | |
| 14 Jan 1999 | 90157060 | Development Credit Bank Ltd. | ₹20 Lakh | Open |
To see the full charge records of Novus Pharmaceuticals Limited, buy the company report.
Total charge records: 14 View all charges
Legal cases
Novus Pharmaceuticals Limited has 5 court cases on record: 5 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 0 |
| High courts | 1 | 1 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Civil suit | Filed against the company by M S Associated Capsules Ltd | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Civil suit | Filed against the company by Assist. Registrar of Companies | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Civil suit | Filed against the company by Assist. Registrar of Companies | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons warrant cases SW) | Filed against the company by an individual | Disposed |
| Bombay High Court | Court case (SS) | Filed against the company by M/S.Associated Capsules Ltd. | Disposed |
To see the full case history of Novus Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Novus Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Novus Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Novus Pharmaceuticals Limited, buy the company report.
Recent activity
Novus Pharmaceuticals Limited has 3 board changes on record since 1995: 3 appointments. The latest: Omprakash Sitaram Saraf was appointed as Director on 26 Jun 1995.
18 earlier events are in the company report.
Frequently asked questions
Novus Pharmaceuticals is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 June 1995 (31+ years old) and is registered under CIN U24230MH1995PLC089743.
Novus Pharmaceuticals has 3 current directors:
- Pramod Sitaram Saraf - Director
- Omprakash Sitaram Saraf - Director
- Subhashchandra Khetaram Choudhary - Director
The latest financial statements of Novus Pharmaceuticals on record with the MCA are for the year ended 31 March 2010. Its last annual general meeting was held on 30 September 2010. Year-wise statements from 2015 are in the company report.
No. Novus Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Novus Pharmaceuticals is U24230MH1995PLC089743. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novus Pharmaceuticals has 5 court cases on record: 5 filed against it. Most are in the district courts.
Novus Pharmaceuticals was incorporated on 20 June 1995, making it 31+ years old. It is registered with the Registrar of Companies, Mumbai.
Omprakash Sitaram Saraf was appointed as Director on 26 Jun 1995. Pramod Sitaram Saraf was appointed as Director on 20 Jun 1995. Subhashchandra Khetaram Choudhary was appointed as Director on 20 Jun 1995.
The registered office of Novus Pharmaceuticals is at 1723 Shreenath Ind Estatemahakali Rd Andheri E, Mumbai, Maharashtra, India – 400093.
Novus Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.